Literature DB >> 11445880

Interactive technology assessment and wide reflective equilibrium.

R P Reuzel1, G J van der Wilt , H A ten Have, P F de Vries Robbé .   

Abstract

Interactive technology assessment (iTA) provides an answer to the ethical problem of normative bias in evaluation research. This normative bias develops when relevant perspectives on the evaluand (the thing being evaluated) are neglected. In iTA this bias is overcome by incorporating different perspectives into the assessment. As a consequence, justification of decisions based on the assessment is provided by stakeholders having achieved agreement. In this article, agreement is identified with wide reflective equilibrium to show that it indeed has the potential of justifying decisions. We work out several conditions for this agreement to be achievable and just.

Entities:  

Keywords:  Health Care and Public Health

Mesh:

Year:  2001        PMID: 11445880     DOI: 10.1076/jmep.26.3.245.3015

Source DB:  PubMed          Journal:  J Med Philos        ISSN: 0360-5310


  4 in total

Review 1.  One of these things is not like the others: the idea of precedence in health technology assessment and coverage decisions.

Authors:  Mita Giacomini
Journal:  Milbank Q       Date:  2005       Impact factor: 4.911

2.  Transformation of the Doctor-Patient Relationship: Big Data, Accountable Care, and Predictive Health Analytics.

Authors:  Seuli Bose Brill; Karen O Moss; Laura Prater
Journal:  HEC Forum       Date:  2019-12

3.  Ethical analysis to improve decision-making on health technologies.

Authors:  Samuli I Saarni; Bjørn Hofmann; Kristian Lampe; Dagmar Lühmann; Marjukka Mäkelä; Marcial Velasco-Garrido; Ilona Autti-Rämö
Journal:  Bull World Health Organ       Date:  2008-08       Impact factor: 9.408

4.  Ethical analysis in HTA of complex health interventions.

Authors:  Kristin Bakke Lysdahl; Wija Oortwijn; Gert Jan van der Wilt; Pietro Refolo; Dario Sacchini; Kati Mozygemba; Ansgar Gerhardus; Louise Brereton; Bjørn Hofmann
Journal:  BMC Med Ethics       Date:  2016-03-22       Impact factor: 2.652

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.